Suppr超能文献

大鼠肝脏微粒体中1,25-二羟基维生素D的合成

1,25-Dihydroxyvitamin D synthesis in rat liver microsomes.

作者信息

Negrea L A, Slatopolsky E, Dusso A S

机构信息

Washington University School of Medicine, Department of Internal Medicine, St. Louis, Missouri, USA.

出版信息

Horm Metab Res. 1995 Oct;27(10):461-4. doi: 10.1055/s-2007-980002.

Abstract

Previous studies from our laboratory have shown 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] production by rat liver homogenates and a low affinity of the hepatic enzyme for 25-hydroxyvitamin D3. Because the liver microsomal vitamin D-25-hydroxylase is the main source of systemic 25(OH)D3, we examined the subcellular location and the kinetics of liver 1,25(OH)2D3 production. Unlike the renal 1 alpha-hydroxylase activity which was assayed simultaneously, 1,25(OH)2D3 synthesis was undetectable in rat liver mitochondria, whereas in microsomes, 1,25(OH)2D3 production followed typical Michaelis Menten kinetics with a Km for 25(OH)D3 of 13.4 microM and a Vmax of 109.8 pg/min per mg protein accounting for most of the 1,25(OH)2D3 synthesized by rat liver cytosol free homogenates. Thus, microsomes are the site for 1,25(OH)2D3 synthesis in the rat liver. This microsomal compartmentalization of the two major steps in the activation of vitamin D to 1,25(OH)2D3 suggests a role for the liver as an autocrine/paracrine organ for 1,25(OH)2D3.

摘要

我们实验室之前的研究表明,大鼠肝脏匀浆可产生1,25 - 二羟基维生素D3 [1,25(OH)2D3],且肝脏酶对25 - 羟基维生素D3的亲和力较低。由于肝脏微粒体维生素D - 25 - 羟化酶是全身25(OH)D3的主要来源,我们研究了肝脏1,25(OH)2D3产生的亚细胞定位和动力学。与同时检测的肾1α - 羟化酶活性不同,在大鼠肝脏线粒体中未检测到1,25(OH)2D3的合成,而在微粒体中,1,25(OH)2D3的产生遵循典型的米氏动力学,25(OH)D3的Km为13.4 microM,Vmax为109.8 pg/min per mg蛋白质,这占大鼠肝脏游离匀浆合成的大部分1,25(OH)2D3。因此,微粒体是大鼠肝脏中1,25(OH)2D3合成的部位。维生素D激活为1,25(OH)2D3的两个主要步骤在微粒体中的这种分隔表明肝脏作为1,25(OH)2D3的自分泌/旁分泌器官发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验